[Federal Register Volume 66, Number 115 (Thursday, June 14, 2001)]
[Notices]
[Page 32365]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-14963]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel, Transactivation of Fetal Hemoglobin Genes 
for Treatment of Sickle Cell Disease and Cooley's Anemia.
    Date: June 18, 2001.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Chevy Chase Holiday Inn, Terrace Room, 5520 Wisconsin 
Avenue, Chevy Chase, MD 20815.
    Contact Person: Robert B. Moore, Scientific Review 
Administrator, Review Branch, Room 7192, Division of Extramural 
Affairs, National Heart, Lung, and Blood Institute, National 
Institutes of Health, Bethesda, MD 20892, 301-435-3541, 
[email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)


    Dated: June 6, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-14963 Filed 6-13-01; 8:45 am]
BILLING CODE 4140-01-M